Uniform and Scalable EB Formation for Drug Discovery and Regenerative Medicine Applications


The developmental versatility of pluripotent stem cells (PSCs) offers a powerful approach for directing cell fate, and these cells are a promising source of progenitors and terminally differentiated somatic cells for cell replacement therapy and drug screening applications. In culture, PSCs have a unique trait of unlimited propagation while retaining their inherent potential to differentiate into cells from the three embryonic germ layers. When plated onto a non-adherent culture dish, these cells aggregate to form embryoid bodies (EBs) which undergo a process of spontaneous differentiation that closely imitates early human embryogenesis.

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.